A Comprehensive Analysis of the Association Between the EORTC QLQ‐C30 Questionnaire and Cachexia in Patients With Gastric Cancer
Journal of Cachexia, Sarcopenia and Muscle · 2025
DOI: 10.1002/jcsm.13859 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Xi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical…. Hauptthemen laut MEDLINE: Cachexia, Stomach Neoplasms, Quality of Life. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, National Basic Research Program of China.
Abstract (Originalsprache)
Background
Cancer cachexia is associated with poor quality of life (QoL) and reduced survival in patients with cancer. The European Organization for Research and Treatment of Cancer (EORTC) QLQ‐C30 is a widely used cancer‐specific health‐related QoL questionnaire that comprises 15 scales, consisting of five multi‐item functional scales, three multi‐item symptom scales, six single‐item symptom scales and a global health and quality‐of‐life scale. Our study aimed to analyse the association of each scale in the EORTC QLQ‐C30 questionnaire with cachexia and explore its influence on survival outcomes in patients with gastric cancer and cachexia.
Methods
This multicentre cohort study enrolled 3158 patients with gastric cancer, among whom 1711 were diagnosed with cachexia. Logistic regression analysis was conducted to identify the individual scales of the EORTC QLQ‐C30 questionnaire significantly affected by cachexia. The Cox model was employed to evaluate the prognostic performance of EORTC QLQ‐C30 questionnaire scales in patients with gastric cancer and cachexia.
Results
In this study, the median age of patients with gastric cancer was 67.00 (interquartile range [IQR], 58.00–74.00) years, with 2178 (69.0%) men and 980 (31.0%) women. In logistic regression analyses, scales such as physical function ( p < 0.001), global quality of life ( p = 0.022), fatigue ( p < 0.001), nausea and vomiting ( p < 0.001), dyspnoea ( p = 0.004), insomnia ( p = 0.007), loss of appetite ( p < 0.001), constipation ( p < 0.001), diarrhoea ( p = 0.017) and summary score ( p = 0.039) were significantly associated with cachexia in patients with gastric cancer. According to the receiver operating characteristics (ROC) curves, loss of appetite was the most significant scale associated with cachexia. Based on multivariate Cox analyses, the scales of physical function (HR = 1.33, 95% CI = 1.00–1.77, p = 0.049), role function (HR = 1.48, 95% CI = 1.15–1.90, p = 0.002), social function (HR = 1.90, 95% CI = 1.40–2.56, p < 0.001), global quality of life (HR = 1.45, 95% CI = 1.05–2.00, p = 0.026), financial impact (HR = 1.53, 95% CI = 1.15–2.03, p = 0.003) and summary score (HR = 1.39, 95% CI = 1.01–1.91, p = 0.042) were independent risk factors for survival in patients with gastric cancer and cachexia. The concordance index (C‐index) and area under the curve (AUC) value for survival prediction were the highest for the social function scale.
Conclusion
The QoL of gastric cancer patients with cachexia was significantly reduced. Certain scales in the EORTC QLQ‐C30 were significantly associated with cachexia, especially the loss of appetite scale, and survival outcomes in patients with gastric cancer, especially social function. Emphasizing these scales can heighten our awareness of the impact of cachexia on QoL and enhance our ability to predict the survival of patients with gastric cancer and cachexia. Trial Registration: ChiCTR: 1800020329
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China.
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China.
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.
- Cancer Center of the First Hospital of Jilin University, Changchun, China.
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
- National Basic Research Program of China
Zitieren
APA
Zhang, X., Dai, X. T., Wang, C., Huang, J. X., Jia, P. P., Tang, M., Song, C. H., Li, W., Shi, H. P., & Cong, M. H. (2025). A Comprehensive Analysis of the Association Between the EORTC QLQ‐C30 Questionnaire and Cachexia in Patients With Gastric Cancer. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13859
Vancouver
Zhang X, Dai XT, Wang C, Huang JX, Jia PP, Tang M, et al. A Comprehensive Analysis of the Association Between the EORTC QLQ‐C30 Questionnaire and Cachexia in Patients With Gastric Cancer. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13859
BibTeX
@article{Zhang2025,
author = {Zhang, Xi and Dai, Xiang-Ting and Wang, Chao and Huang, Jia-Xin and Jia, Ping-Ping and Tang, Meng and Song, Chun-Hua and Li, Wei and Shi, Han-Ping and Cong, Ming-Hua},
title = {A Comprehensive Analysis of the Association Between the EORTC QLQ‐C30 Questionnaire and Cachexia in Patients With Gastric Cancer},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
doi = {10.1002/jcsm.13859}
}
EUVIMED